Takeda spotlights ORZEYFUL approvals and raises FY2026 forecast as reported operating profit jumps
Market Chameleon (Fri, 30-Oct 11:53 AM)
Takeda’s ORZEYFUL debuts in Japan and China after approvals within a month, putting a first-in-class orexin agonist into clinicians’ hands
Market Chameleon (Thu, 15-Oct 7:38 AM)